US10968453 — Compositions for modulating SOD-1 expression
Method of Use · Assigned to Biogen MA Inc · Expires 2035-04-01 · 9y remaining
What this patent protects
This patent protects methods and compositions for decreasing SOD-1 expression to treat or prevent amyotrophic sclerosis (ALS) and other SOD-1 associated diseases.
USPTO Abstract
Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).
Drugs covered by this patent
- Qalsody (TOFERSEN) · Biogen Ma
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3575 |
— | Qalsody |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.